Blar i Bergen Open Research Archive på forfatter "Farbu, Elisabeth"
-
Brain atrophy and clinical characteristics predicting SDMT performance in multiple sclerosis: A 10-year follow-up study
Jacobsen, Cecilie; Zivadinov, Robert; Myhr, Kjell-Morten; Dalaker, Turi Olene; Dalen, Ingvild; Benedict, Ralph H.B.; Bergsland, Niels; Farbu, Elisabeth (Journal article; Peer reviewed, 2021)Objectives To identify Magnetic Resonance Imaging (MRI), clinical and demographic biomarkers predictive of worsening information processing speed (IPS) as measured by Symbol Digit Modalities Test (SDMT). Methods Demographic, ... -
Brain atrophy and employment in multiple sclerosis patients: a 10-year follow-up study
Jacobsen, Cecilie; Zivadinov, Robert; Myhr, Kjell-Morten; Dalaker, Turi Olene; Dalen, Ingvild; Bergsland, Niels; Farbu, Elisabeth (Journal article; Peer reviewed, 2020)Background: Multiple sclerosis is often associated with unemployment. The contribution of grey matter atrophy to unemployment is unclear. Objectives: To identify magnetic resonance imaging biomarkers of grey matter and ... -
CSF neurofilament light chain predicts 10-year clinical and radiologic worsening in multiple sclerosis
Bhan, Alok; Jacobsen, Cecilie; Dalen, Ingvild; Bergsland, Niels; Zivadinov, Robert; Alves, Guido Werner; Myhr, Kjell-Morten; Farbu, Elisabeth (Journal article; Peer reviewed, 2021)Background Neurofilament light chain (NfL) is an attractive biomarker of disease activity and progression in MS, but there is a lack in long-term prognostic data. Objective To test the long-term clinical and radiological ... -
Gut microbiota composition during a 12-week intervention with delayed-release dimethyl fumarate in multiple sclerosis – a pilot trial
Storm-Larsen, Christopher; Myhr, Kjell-Morten; Farbu, Elisabeth; Midgard, Rune; Nyquist, Kaja Beate; Broch, Line; Berg-Hansen, Pål; Hov, Johannes Espolin Roksund; Holmøy, Trygve (Peer reviewed; Journal article, 2019)Introduction: Patients with multiple sclerosis may have a distinct gut microbiota profile. Delayed-release dimethyl fumarate is an orally administered drug for relapsing–remitting multiple sclerosis, which has been associated ... -
Treatment approach and survival from glioblastoma: results from a population-based retrospective cohort study from Western Norway
Bjorland, Line Sagerup; Fluge, Oystein; Gilje, Bjornar; Mahesparan, Rupavathana; Farbu, Elisabeth (Journal article; Peer reviewed, 2021)Objectives To evaluate treatment and survival from glioblastoma in a real-world setting. Design and settings A population-based retrospective cohort study from Western Norway. Participants 363 patients aged 18 ...